Nearly 25% of patients with ulcerative colitis requiring steroids therapy become steroid-dependent after 1 year, and virtually all develop steroid-related adverse events. The authors investigate the efficacy and safety of dexamethasone 21-P encapsulated into erythrocytes. The American Journal of Gastroenterology
